Mumbai, Aug. 8 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Prucalopride Tablets, 1 mg and 2 mg (USRLD: Motegrity (R) Tablets, 1 mg and 2 mg).

Published by HT Digital Content Services with permission from Capital Market....